|
 |
LantusThis page contains recent news articles, when available, and an overview of Lantus but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Lantus (when available) Used in the treatment of type I and type II diabetes. The primary activity of insulin is the regulation of glucose metabolism. In muscle and other tissues (except the brain), insulin causes rapid transport of glucose and amino acids intracellularly. It also promotes anabolism, and inhibits protein catabolism. In the liver, insulin promotes the uptake and storage of glucose in the form of glycogen, inhibits gluconeogenesis, and promotes the conversion of excess glucose into fat. For treatment of diabetes (type I and II) Mechanism Of Action: Insulin binds to the insulin receptor (IR), a heterotetrameric protein consisting of two extracellular alpha units and two transmembrane beta units. The binding of insulin to the alpha subunit of IR stimulates the tyrosine kinase activity intrinsic to the beta subunit of the receptor. The bound receptor is able to autophosphorylate and phosphorylate numerous intracellular substrates such as insulin receptor substrates (IRS) proteins, Cbl, APS, Shc and Gab 1. These activated proteins, in turn, lead to the activation of downstream signaling molecules including PI3 kinase and Akt. Akt regulates the activity of glucose transporter 4 (GLUT4) and protein kinase C (PKC) which play a critical role in metabolism and catabolism. News Articles on Insulin Glargine recombinant Janotův balÃÄ?ek mÄ›l léky zlevnit. Pacienti ale platà vÃc - 05 Jan 2010 Astmatici, kteřà potÅ™ebujà pÅ™Ãpravek Lantus, zaplatà o 113 korun vÃc. Pacienti, kteřà užÃvajà Hydrochlorothiazid na snÞenà krevnÃho tlaku a na odvodnÄ›nà ... Týden.cz Roche, Ipsen diabetes drug meets goals in studies - Dec 17, 2009 PA) daily insulin treatment Lantus, or glargine, in controlling blood sugar in one of the Phase III trials and better than a placebo in overweight patients ... Reuters Roche's weekly diabetes medicine as effective as Lantus - Dec 20, 2009 A new experimental weekly diabetes drug taspoglutide from Roche was found in a phase III trial as good as Sanofi-Aventis's daily insulin treatment Lantus or ... Food Consumer Sanofi-Aventis to buy Chattem for about $1.9B - Dec 22, 2009 Sanofi-Aventis makes diabetes treatment Lantus (insulin glargine), a long-acting basal insulin analogue, and Tritace (ramipril) an ACE inhibitor indicated ... NephrOnline Niche health site reports traffic jump - Dec 30, 2009 ...following companies have recently aired ads against the TV show: Merck for Januvia, Sanofi-Aventis for Lantus and Roche for its AccuCheck glucose meter. ... Medical Marketing and Media Sanofi-Aventis eyes stake in Zealand Pharma - Dec 23, 2009 Sanofi aims to widen its offer of drugs against diabetes as well as double the sales of its Lantus insulin in 2012 from EUR2.4bn in 2008. ... Behavioral Health Central (blog) Prescription drugs stolen from car in Hagley - Dec 29, 2009 Items taken included a black handbag containing two insulin pens, (a blue pen called Novorapid and a grey pen called Lantus Solostar) and two packets of ... Stourbridge News Is Lantus Insulin Linked to Increased Risk of Cancer? New Study Begins - Dec 17, 2009 Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a ... A Sweet Life (blog) Public versus private sector drug plans: pricing not the only issue - Dec 15, 2009 Let's take the example of Lantus (insulin glargine), a long-acting insulin product that has been available for sale in Canada for years. ... Benefits Canada India's Rich Pickings For Pharma M&A - Dec 18, 2009 ...that sells a cut-price version of Sanofi-Aventis's insulin analogue Lantus and includes a biosimilars business, currently a hot area for big pharma. ... Wall Street Journal (blog) Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About ... - Dec 16, 2009 Avandia (GlaxoSmithKline), Januvia (Merck), Onglyza (AstraZeneca Bristol-Myers Squibb), Lantus (sanofi-aventis), Humalog (Lilly), and Actos (Tekeda). ... PR Newswire (press release) Ready to rumble: Pfizer's generic biotech drug push could pit it against Amgen - Dec 11, 2009 Sanofi-Aventis' Lantus could be the most affected. And Pfizer is not the only one seeing the field's potential. Merck (MRK) announced plans last year to ... Daily Finance (blog) Sanofi-Aventis Names New Chairman - Dec 16, 2009 ...and directed a private investment fund. Sanofi-Aventis is best known for making blood thinners Lovenox and Plavix, and the diabetes treatment Lantus. Manufacturing.net Amylin Impresses in Head-to-Head - Dec 16, 2009 Report) Januvia and Takeda's Actos, the DURATION-3 study proved exenatide once weekly to be superior to Sanofi-Aventis' (SNY - Analyst Report) Lantus. ... Zacks.com Diabetikům a astmatikům letos výraznÄ› zdražà nÄ›které léky - Jan 4, 2010 ..."NapÅ™Ãklad u inzulÃnu Lantus se zvýšenà spoluúÄ?asti pohybuje řádovÄ› na sto deseti, sto tÅ™inácti korunách za jedno balenÃ. To je lék, který použÃvajà ... Český rozhlas European Market Update: Weaker UK retail sales data adds to Europe's woes ... - Dec 17, 2009 SZ]: Taspoglutide meets primary endpoints in Phase III studies with insulin glargine (Lantus(R). || VTB [VTBR.RU]: Reports Q3 Net loss RUB15B v loss RUB8Be; ... Fxtraders.eu Sanofi-aventis : Cherche le successeur du Lantus chez une biotech danoise - Dec 23, 2009 Un candidat médicament prometteur, actuellement en phase III d'essais clinique, qui pourrait ainsi venir épauler l'anti-diabétique Lantus, le troisième ... Trading Sat Online-Sprechstunde: Können Hunde Hämorrhoiden bekommen? - Jan 4, 2010 Im Internet habe ich ein Präparat namens "Lantus" gefunden. Aber das kennt niemand, den ich bisher gefragt habe, Erfahrungswerte. ... Derwesten.de SANOFI-AVENTIS : Oddo a relevé son objectif de cours - Jan 4, 2010 ...l'anti-arythmique Multaq, homologué le 2 juillet aux Etats-Unis et dont la commercialisation était prévue pour l'été 2009, et (ii) l'insuline Lantus. ... TF1 Ipsen-Taspoglutide atteint ses critères dans de nouvelles études - Dec 16, 2009 Le taspoglutide démontre une "non-infériorité" vis-à -vis de l'insuline glargine - le Lantus de Sanofi-Aventis (SASY.PA: Cotation) - et une "supériorité ... Reuters Roche: Taspoglutid atteint le critère primaire dans 2 études Phase III - Dec 16, 2009 Les études ont comparé ce médicament en prise hebdomadaire avec Lantus d'Aventis et un placebo chez des patients présentant un indice de masse corporelle ... Romandie.com 로슈 당뇨병 실험약, '란투스'와 비슷한 효과 ë³´ì—¬ - Dec 17, 2009 ...입센과 로슈가 개발 중ì?¸ 당뇨병 ì¹˜ë£Œì œ 타스í?¬ê¸€ë£¨íƒ€ì?´ë“œ(taspoglutide)ê°€ 사노피ì?˜ '란투스(Lantus)'와 위약과 비êµ?하는 ìž„ìƒ?시험ì—?ì„œ 주요 목표ì—? ë?„달한 것으로 ... 메디게이트뉴스 金èž?风暴末时代 制è?¯å·¨å¤´ç§¯æž?多元化å?‘展 - Dec 22, 2009 ...“对赛诺è?²å®‰ä¸‡ç‰¹æ?¥è¯´ï¼Œé™†ç»å®£å¸ƒè¿™äº›äº¤æ˜“行动是个好时机，我们å?¯ä»¥è®¤ä¸ºæœ‰å…³Lantus的问题æ£åœ¨è¿‡åŽ»ã€‚â€?分æž?师Lanone表示，赛诺è?²å®‰ä¸‡ç‰¹ä¸?ä»…è¦?借助这些新的å??议增强产å“? ... 中国生物技术信息网 Pharma-Industrie: Die Deutschen schlucken immer mehr Pillen - Dec 18, 2009 Als Lantus einen Festpreis bekam und die Kassen zunächst nicht mehr zahlten, gab es böse Schlagzeilen. Ohne jede Not: Erstens konnte keine bessere ... Derwesten.de 로슈, 당뇨 ì‹ ì•½ 타스í?¬êµ¬ë£¨íƒ€ì?´ë“œ ìž„ìƒ?ê²°ê³¼ 만족 - Dec 21, 2009 ...김윤ì˜? 기ìž? 주 1회 투여하는 로슈ì?˜ 새로운 당뇨 ì¹˜ë£Œì œ 타스í?¬êµ¬ë£¨íƒ€ì?´ë“œ(taspoglutide)ê°€ ì œ3ìƒ? ìž„ìƒ?시험ì—?ì„œ ê²½ìŸ? 약품ì?¸ 사노피-아벤티스ì?˜ 란투스(Lantus: ... 메디포뉴스 Roche: Taspoglutid erreicht primäre Endpunkte in zwei Phase-III-Studien - Dec 16, 2009 Die Studien hätten den Produktkandidaten bei einer einmal wöchentlichen Abgabe mit Lantus (Insulin Glargin von Aventis) und einem Placebo bei Patienten mit ... Handelszeitung Online Sanofi-Aventis "buy" - Dec 10, 2009 Die beiden größten Präparate Lantus (weltweit führend bei Insulin, Umsatz +21,7%) und Lovenox (+13,7%) hätten in allen drei Regionen gut abgeschnitten. ... newratings.de Ypsomed-CEO blickt nach Asien: «Das Sparpotenzial muss ausgeschöpft werden» - Dec 17, 2009 Sanofi-Aventis ist dank dem Insulin Lantus, heute die Hauptumsatzquelle des Konzerns, ein sehr grosser Kunde geworden. Aber wir hatten nie Probleme mit ... stocks No added sugar: living with diabetes - 14 Nov 2009 However, when I got back home, I suddenly lost my confidence and I actually took nearly an hour to have my Lantus (insulin glargine injection). ... Streetbrand Sanofi 3Q Pft +6.8%; Ups Target On Swine Flu Vaccine - Oct 30, 2009 Double-digit sales growth of diabetes drug Lantus and blood thinner Lovenox helped offset a steep drop in sales of cancer treatment Eloxatin, which were hit ... Wall Street Journal Mark your calendar: World Diabetes Day - Nov 11, 2009 The Lantus ClickSTAR reusable pen, now available in Canada, provides patients with an easier way to selfadminister their insulin injections and achieve ... Caledon Citizen Sanofi snags diabetes drug in $350M licensing pact - Oct 21, 2009 Sanofi markets Lantus, a blockbuster diabetes drug that is its second-biggest therapy on the market. This is just the latest in a string of deals for the ... FierceBiotech Protecting Pharmaceutical Profits: The Cost Is Human Lives - Oct 27, 2009 Embrel and Remicade, for rheumitoid arthritis, Rituxan, for Non-Hodgkin's lymphpoma, Avasta, for metastatic colorectal cancer, Lantus, for diabetes, ... Huffington Post (blog) Diabetes sufferers to finally get free insulin pens - Oct 26, 2009 Under the free medicine benefit, diabetes sufferers who use insulin solutions Lantus and Aspart have to use syringes, unless they are under 16 years of age. ... Malta Today Many mornings I wake up covered in sweat. Could this be a sign of night time ... - Oct 30, 2009 It happens much more with the older insulins like NPH, which have a peak in action, as compared to the newer long acting insulins like glargine (Lantus), ... A Sweet Life, the source for the healthy diabetic (blog) Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009 - Oct 30, 2009 Taking into account the performance over the first 9 months of the year (net sales of euro 2317 million, a rise of 24.9%), Lantus® has become the Group's ... Reuters Strong 3Q so far bodes well for Astra and Glaxo - Oct 26, 2009 Turning to Sanofi-Aventis, while we expect downward pressure on sales of diabetes drug Lantus because of reported links to cancer, the lack of robust media ... Hemscott ADR REPORT: ADRs Fall As US Stocks, French Shares Tumble - Oct 30, 2009 FR) on Friday reported a 6.8% rise in third-quarter net profit due to robust sales growth of blockbuster drugs Lantus and Lovenox, and raised full-year ... Wall Street Journal Living Without Blockbusters - Oct 28, 2009 When the drug safety police this year linked Lantus, the company's $4-billion-a-year long-acting insulin, to cancer, he responded quickly, assembling a ... Forbes Pet Health Notice: FDA Issues Alert on Pet Insulin Product - Nov 6, 2009 ..."Examples of alternative insulin choices include Humulin N and Levemir insulins for dogs, and Lantus (glargine) insulin for cats. ... Connecticut Post Shrugging Off the Side Effects - Oct 31, 2009 ...sanofi-aventis' (NYSE: SNY) long-lasting insulin Lantus is linked to cancer, and what happens to sales? ... The Money Times Amylin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript - Oct 20, 2009 To date DURATION-1, 2 and 3 have provided exciting results demonstrating compelling efficacy with exenatide once weekly against Actose, Januvia, Lantus and ... Seeking Alpha (blog) And the Award goes to.... - Oct 29, 2009 Sanofi-Aventis and Euro RSCG Life MetaMax took home the Silver Award in the category with their cycling campaign on behalf of Lantus for type 2 diabetes. ... Medical Marketing and Media Pre-Market Stock Upgrades/Downgrades Oct 30, 2009 - Oct 30, 2009 ...drugs Lantus and Lovenox, and raised full-year guidance, citing an expected $500 million boost to fourth-quarter sales from the swine-flu vaccine. ... Wall Street Pit (blog) Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes - Oct 22, 2009 LANTUS trial. Diabetes Obes Metab 2008;10:387-399. [CrossRef][Web of Science][Medline] Rosenstock J, Ahmann AJ, Colon G, Scism-Bacon J, Jiang H, ... New England Journal of Medicine (subscription) Sanofi-Aventis boekt winstgroei 6,8%; verhoogt outlook - Oct 30, 2009 Sanofi-Aventis zag dankzij een dubbelcijferige omzetgroei van diabetesmedicijn Lantus en bloedverdunner Lovenox de omzet met 8% klimmen tot euro 7,4 mrd. ... Financieele Dagblad Sanofi-Aventis erhöht Ausblick - Oct 30, 2009 ..."Die Wachstumstreiber der nächsten fünf Jahre werden unsere wichtigsten Diabetesprodukte wie Lantus, aber auch das Impfstoffe-Geschäft, die Schwellenländer, ... derStandard.at 'Link' met kanker leidt tot onrust - Oct 28, 2009 Europese wetenschappers hadden de kat de bel aangebonden in juni, toen ze in het vakblad Diabetologia rapporteerden dat Lantus, het best verkopende ... De Standaard Sanofi-Aventis supera previsiones, apoyada por las vacunas contra la gripe A - Oct 30, 2009 Las ventas de Lantus aumentaron un 27,1%, hasta los 778 millones, mientras que las de Plavix lo hicieron en un 5,6%, hasta los 664 millones. ... Bolsamania.com Sanofi-Aventis en forme - Oct 30, 2009 ...le Lantus (+21,7%) et le Plavix (+4,1%), qui ont permis de compenser l'impact négatif de la concurrence des génériques d'Eloxatine aux Etats-Unis (-18 ... La Tribune.fr Argentina: hay 1 millón de diabéticos no diagnosticados - Nov 12, 2009 Buenos Aires sanofi aventis se comprometió donar cartuchos de insulina glargina (Lantus®) y viales de insulina humana ADN recombinante (Insuman®) para ... Asteriscos HIGHLIGHTS CORPORATE - Oct 30, 2009 La societa' francese Sanofi-Aventis ha riportato una crescita degli utili del 6,8% nel terzo trimestre, trainata dalle vendite dei farmaci Lantus e Lovenox ... Borsa Italiana Sanofi-aventis : Jefferies prudent sur le potentiel du Multaq - Nov 10, 2009 Il juge en effet le titre pleinement valorisé au regard du risque générique concernant le Lovenox, et des risques sur la sécurité du Lantus et la politique ... Trading Sat Sanofi-Aventis alza le sue stime per l'intero esercizio - Oct 30, 2009 Sanofi-Aventis ha beneficiato soprattutto del forte aumento delle vendite del Lantus. Il giro d'affari dell'insulina a lenta cessione è cresciuto lo scorso ... Borsa inside.com Diabete: l'Insulina Glargine è associata a rischio tumore ? - Nov 5, 2009 L'FDA sta attualmente revisionando i dati sulla sicurezza di Lantus, tra cui i dati degli studi osservazionali pubblicati, i dati di tutti gli studi clinici ... XagenaSalute 赛诺è?²-安万特第三å£åº¦å‡€åˆ©æ¶¦å¢žé•¿6% - Oct 30, 2009 ...市场对赛诺è?²-安万特畅销è?¯å“?æŠ—è¡€æ “è?¯ä¾?诺è‚?ç´ (Lovenox)以å?Šç³–尿病治疗è?¯Lantus的强劲需求为该公å?¸ç¬¬ä¸‰å£åº¦æ•´ä½“è?¯å“?é”€å”®å¥ å®šäº†ç¨³å›ºçš„åŸºç¡€ã€‚ 赛诺è?²-安万特今年å‰?9个月 ... 新浪网 Sanofi-Aventis prend le contrôle d'un fabricant russe d'insuline - Oct 25, 2009 Le groupe est très présent dans le traitement du diabète avec son insuline Lantus, troisième produit de l'entreprise après le Lovenox et le Plavix. ... Les Échos Sanofi-Aventis si-a majorat estimarea de profit - Oct 30, 2009 ...cauta in afara laboratoarelor grupului produse si companii care sa sustina cresterea vanzarilor, alaturi de Lantus, medicamentul pentru diabet. ... Wall-Street Nyhet i Sverige: Ny lätthanterlig insulinpenna för personer med diabetes - Oct 29, 2009 ClikSTAR är en ny flergÃ¥ngspenna som har utvecklats för det lÃ¥ngverkande insulinet Lantus och mÃ¥ltidsinsulinet Apidra. ClikSTAR är framtagen genom en tät ... MyNewsdesk (pressmeddelande) Прибыль «sanofi-aventis» в III кв. возроÑ?ла на 16% - Nov 2, 2009 Объем продаж Lantus в III кв. Ñ?оÑ?тавил 22% или 778 млн евро (1,2 млрд дол. СШÐ?), в то времÑ? как доход от продаж Lovenox выроÑ? на 14% и доÑ?тиг 747 млн евро ... Аптека online Medicamentele pentru diabetici au majorat profitul Sanofi-Aventis - Nov 1, 2009 ...caută în afara laboratoarelor grupului produse ÅŸi companii care să susÅ£ină creÅŸterea vânzărilor, alături de Lantus, medicamentul pentru diabet. ... Curierul National Sanofi-Aventis anticipe une hausse de 11 % de son BPA 2009 grâce au vaccin H1N1 - Nov 1, 2009 ...+22% pour Lantus, +14% pour Lovenox, +4% pour Plavix, «nous n'anticipons pas d'inflexion de tendance sur la fin de l'année, poursuit Jérôme Contamine. ... L'AGEFI 사노피, M&A 통해 새 당뇨약 개발계íš? 모색 - Oct 23, 2009 ...사를 3ì–µ 5천만 달러ì—? ì?¸ìˆ˜í•˜ë¯€ë¡œ 현재 최대 매출ì?„ ìž?랑하는 ì?¸ìŠ?린 란투스(Lantus)ë¡œ 구축한 당뇨 치료사업ì—? 새로운 당뇨 ì‹ ì•½ 파ì?´í”„ë?¼ì?¸ì?„ ë³´ê°•í• ê²ƒìœ¼ë¡œ ë³´ì?¸ë‹¤ ... 메디포뉴스 Sanofi alarga carteira de tratamentos da diabetes - Oct 21, 2009 ...para expandir a sua carteira de tratamentos da diabetes, agora liderada pelo blockbuster de insulina Lantus®, avança a agência Bloomberg. ... RCM Pharma Le nouveau stylo écologique Lantus(R) ClikSTAR(MC) disponible au Canada - Oct 19, 2009 .../CNW/ - Santé Canada a approuvé le stylo réutilisable d'insuline ClikSTAR pour une utilisation avec Lantus, ce qui donnera aux patients atteints de diabète ... LeLézard.com Sanofi-aventis och Wellstat Therapeutics ingÃ¥r ett exklusivt världsomspännande ... - Oct 27, 2009 Efter att ha stÃ¥tt i förgrunden när det gäller innovationer inom diabetes, särskilt med insulinet Lantus (insulin glargin), ger PN2034 oss nu en möjlighet ... MyNewsdesk (pressmeddelande) US futures: prozatÃm oddech - Oct 30, 2009 EUR, prodeje insulinu Lantus rostly o 27,1 % na 778 mil . EUR, prodeje Plavixu rostly o 5,6 % na 664 mil . EUR, dÃky zvýšené poptávce po vakcÃnách proti ... Kurzy.cz Euronext en Europa: beurzen overwegend lager - Oct 30, 2009 ...van 2009 de nettowinst met 6,8% zien stijgen tot euro 1,42 mrd, geholpen door een robuste omzetgroei van de belangrijke medicijnen Lantus en Lovenox. ... Financieele Dagblad Citigroup Corp. stuft SANOFI-AVENTIS auf buy - Nov 3, 2009 Die Absatzentwicklung von Plavix, Lantus und Impfstoffen sei aber besser als angenommen gewesen. Eloxatin habe auf Grund eines schärferen generischen ... wallstreet-online 21/10/09 07:05 Sanofi-aventis : rachète à Wellstat un antidiabétique en ... - Oct 20, 2009 ...de sensibilisation à l'insuline pour un traitement oral", explique le laboratoire déjà leader dans le domaine du diabète, avec Lantus notamment. ... Challenges CONSENSUS Sanofi Net pdg T3 vu à +13%, BPA à +9,6%, CA à +8,5% - Oct 27, 2009 MOYENNE VARIATION PAR RAPPORT A 2008 Lantus (diabète) 756,6 +23,6% Lovvenox (thrombose) 728,4 +14,7% Plavix (thrombose) 638,3 + 1,3% Taxotère (cancer) 554,5 ... Reuters ФранцузÑ?каÑ? компаниÑ? купила роÑ?Ñ?ийÑ?кого производителÑ? инÑ?улина - Oct 26, 2009 ИнÑ?улин Lantus Ñ?влÑ?етÑ?Ñ? третьим по важноÑ?ти продуктом предприÑ?тиÑ? поÑ?ле препаратов Lovenox и Plavix. Sanofi-Aventis уже говорила в Ñ?том году и о других ... inoСМИ.Ru Креатив помогает бизнеÑ?у - Oct 28, 2009 Lantus, a new once-a-day insulin, was originally offered in a licensed injector device, but in 2003, in order to sustain development of the new insulin, ... Sostav.ru 세계 ì œë„¤ë¦ì‚¬ ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ 개발 활발 - Oct 20, 2009 ...아울러 ì?¸ë?„ì?˜ ë°”ì?´ì˜¤ì½˜(Bipcon)ì?´ HGH와 '란투스' ì?¸ìŠ?린ì—? 대한 ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ë¥¼ 개발 중ì?´ë©°, 워카르트(Wockhardt)ë?„ '란투스'(Lantus) ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ë¥¼ ë…¸ë¦¬ê³ ìžˆë‹¤. ... 디지틀보사 DIABETIQUE DE TYPE 2 : Lutter contre la résistance à l'insuline - Oct 20, 2009 Ces insulines sont actuellement disponibles en stylo jetable : Insulatard NPH Flexpen, Umuline NPH Pen®), Lantus stylo Solostar®) et Levemir Flexpen®. ... santé log - communauté des professionnels de santé Hypothekenanbieter - Börsen in Europa Schluss: Schwaches Handelsende, Alcatel ... - Oct 30, 2009 Der Pharmakonzern konnte im dritten Quartal dank einer starken Entwicklung des Diabetesmittels Lantus ein Ergebnisplus erzielen. ... Ad-Hoc-News (Pressemitteilung) Sanofi's Lantus insulin favored over rival: study - Mar 27, 2008 LONDON (Reuters) - A once-daily injection of Sanofi-Aventis's insulin drug Lantus controls blood sugar as effectively as Eli Lilly's Humalog, which needs to ... Reuters Sanofi's Lantus insulin favored over rival: study - Mar 28, 2008 LONDON (Reuters) - A once-daily injection of Sanofi-Aventis's insulin drug Lantus controls blood sugar as effectively as Eli Lilly's Humalog, which needs to ... Reuters India Two new competitors won't take down Lantus, analysts say. - Jun. 28, ... - Jun 28, 2005 By Aaron Smith, CNN/Money staff writer. NEW YORK (CNN/Money) – Sanofi-Aventis' diabetes drug Lantus has flourished in the lucrative industry for insulin ... CNNMoney.com Sanofi best-sellers help lift net profit in 3Q - Oct 31, 2008 French pharmaceutical giant Sanofi-Aventis said Friday that higher sales of blood thinners Lovenox and Plavix and diabetes treament Lantus helped lift net ... FOXNews Sanofi Profit Rises 15%, Led by Lantus and Vaccines - Aug 2, 2006 By Angela Cullen. Aug. 2 (Bloomberg) -- Sanofi-Aventis SA, the world's third- largest drugmaker, said second-quarter profit rose 15 percent as growth from ... Bloomberg Improved insulin now available in Canada - Feb 17, 2005 The insulin glargine, sold in the US under the brand name Lantus, ... The molecular nature of Lantus has no peak action, meaning fewer low blood sugars. ... CBC.ca Novo Nordisk jumps on postive data for diabetes drug - MarketWatch - Jun 21, 2007 Lantus, an insulin product that needs to be injected only once a day, is marketed by Sanofi-Aventis. Thomsen said that Novo Nordisk sees potential sales of ... MarketWatch … (R), the First Prefilled Disposable Insulin Pen for Lantus(R), is... - Jul 30, 2007 ..."Lantus(R) has been proven to help lower blood sugar levels and can help ... Lantus(R) is the only 24-hour insulin approved exclusively for use once a day. ... Free with registration - PR Newswire - AccessMyLibrary.com … ADA Showed That Basal Insulin Therapy With Lantus(R) Achieved... - Jun 13, 2005 Further data at the ADA show that Lantus(R) can be safely and effectively ... "These studies re-affirm that Lantus can help more people with type 2 diabetes ... RedOrbit Aventis Pharma open to brand buys, JVs - Apr 29, 2008 Lantus, which had sales of about 280 million rupees in India, is expected to grow at 80 percent, Susheel Umesh, senior director of cardio metabolism ... Reuters India Sanofi-Aventis to launch diabetes pen from April - Mar 16, 2007 SoloSTAR is for use with Sanofi's diabetes treatments Lantus or Apidra and the first launch of SoloSTAR, for Lantus, is planned in Germany, it said. ... Reuters Lantus lows - Sep 15, 2007 I have 52 years, with 21 years of insulin dependent diabetes, 5 years using Lantus.I use 3 rapid insulin bolus in day (pre-meals), and a lantus dose at ... HealthCentral.com Sanofi Says Lantus Insulin Worked in Earlier Stage of Diabetes - Jun 7, 2008 By Trista Kelley. June 7 (Bloomberg) -- Sanofi-Aventis SA's Lantus insulin controlled blood sugar levels for patients in the early stages of diabetes when ... Bloomberg Insulins added to PBS list - Aug 24, 2006 Health Minister Tony Abbott says long-lasting injectable insulins Lantus and Levemir ... Sydney type one diabetic Michael Sluis says he has used Lantus and ... NEWS.com.au Phamac to fund new once-a-day insulin - Jun 26, 2006 Pharmac has announced that Insulin Glargine or Lantus is to be subsidised from July 1. ... He says not everyone who has Type 1 diabetes will get Lantus. ... TVNZ Star Tackles Health Role - Apr 23, 2007 The company makes Lantus, a once-daily, injectable insulin that Turturro began taking about four years ago. Turturro first spoke out about diabetes three ... Washington Post Type 2 Diabetes; Study of 24-hour basal insulin Lantus published - Jul 12, 2005 2005 JUL 12 - (NewsRx.com) -- A global study of nearly 5000 people with type 2 diabetes demonstrated that treatment regimens that included the 24-hour basal ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones European stocks dip as weak banks offset miners - Mar 28, 2008 PA: Quote, Profile, Research) up 2.5 percent, benefiting from results from a study that showed the company's insulin drug Lantus controls blood sugar as ... Reuters UK … New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In... - Apr 30, 2007 BRIDGEWATER, NJ, April 30 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the US Food and Drug Administration (FDA) approved Lantus ... Free with registration - PR Newswire - AccessMyLibrary.com Experts to vote on inhalable insulin from Pfizer, Nektar. - Aug. 30,... - Aug 30, 2005 ..."Fast-acting insulin is something you have to use several times a day. With Lantus, you inject it twice a day and you're done," he said. CNNMoney.com Novo-Nordisk says Levemir insulin as effective as glargine over 24... - Jun 9, 2008 ...blood glucose response to insulin glargine, the active ingredient in Sanofi-Aventis SA's Lantus over a 24-hour period in patients with type 2 diabetes. ... Forbes Lantus - Insulin glargine - Medical Drug - Jan 10, 2006 Lantus (insulin glargine) is a long-acting form of the hormone insulin. It is used to lower blood sugar levels in patients with type 1 or type 2 diabetes ... Virtual Medical Centre - The Virtual Medical Centre Ask the Expert on . . . Lantus Conversion - Jun 16, 2005 Would you please explain how to convert 70/30 insulin coverage to Lantus coverage? When our patients are admitted to the hospital, they are usually ... Medscape Study Shows Lantus(R) Helped People Living with Type 2 Diabetes … - Jun 7, 2008 SAN FRANCISCO , June 7 /PRNewswire-FirstCall/ -- Results from a new study presented at the American Diabetes Association's (ADA) 68th Annual Scientific ... Genetic Engineering News - Genetic Engineering News (press release) Insulin Lantus Lowered Free Fatty Acid Levels Equal To Or Better Than... - Jun 25, 2007 When added to metformin and/or a sulfonylurea, the once-a-day, long-acting insulin Lantus, significantly reduced free fatty acid levels in patients with ... emaxhealth.com More Marketing Wars: Lantus vs. Levemir - Sep 14, 2006 I wrote a post introducing the first-ever competitor to Sanofi-Aventis' long-acting insulin, Lantus. The new product is called Levemir, from Novo Nordisk. ... HealthCentral.com … A1C Lowering And Cost Benefit Observed With LANTUS(R) Over Detemir … - Sep 9, 2008 THIN: For LANTUS(R) and detemir, discounted cost per patient was GBP6,536 and ... Despite higher drug costs for LANTUS(R), relevant savings were observed in ... Medical News Today - Medical News Today (press release) … Care Confirms Basal Therapy with Lantus(R) Improves Glycemic... - Jun 9, 2005 LANTUS, (A Trial comparing Lantus(R) Algorithms to achieve Normal blood ... Participants were randomized to one of two Lantus(R) treatment regimens to be ... $4.95 - PR Newswire - ECNext … (R), the First Prefilled Disposable Insulin Pen for Lantus(R), is... - Jul 30, 2007 SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research You get the beer, and I'll get the Lantus - Nov 28, 2006 The other day, Steph and I were divvying up the shopping that we had to do. I was running low on Lantus, and our refrigerator was also running low on beer, ... HealthCentral.com Aventis Pharma launches SoloStar in India - May 13, 2008 Lantus has a global market of 2 billion Euros. SoloStar reduces the injection force by 30% or more in comparison to other leading disposable pens, he added. ... Business Standard Positive results for Sanofi-Aventis' Lantus.(Brief Article) - Jun 20, 2005 One of the largest prospective treatment trials of diabetes management ever undertaken has revealed that once-daily Lantus (insulin glargine [rDNA origin] ... $4.95 - Pharma Marketletter - ECNext … Head Studies Demonstrated Long-Acting Insulin Lantus(R) Lowered... - Jun 23, 2007 In the comparison between Lantus(R) and rosiglitazone, free fatty acid decreases were similar after 24 weeks, but decreases in triglyceride levels were ... RedOrbit ADA: Improved Safety with Levemir for Diabetes Without Weight Gain - Jun 15, 2006 The analysis included 251 patients who were taking NPH insulin and 260 receiving Lantus prior to the study. The majority continued oral antidiabetic ... MedPage Today Ypsomed Has Record Gain on Sanofi Lawsuit Settlement - Apr 22, 2008 ...``The new SoloStar supply contract will allow Ypsomed to participate in future Lantus and Apidra growth.'' Lantus is Sanofi's fastest-growing product and ... Bloomberg Article: New insulin pen.(PRODUCTS)(Lantus)(Brief article) - Internal... - Nov 1, 2007 New insulin pen.(PRODUCTS)(Lantus)(Brief article) ... find Internal Medicine News articles. The Food and Drug Administration has approved the Lantus ... Pay-Per-View - Internal Medicine News - HighBeam Research Lantus cancer risk? | Article from Townsend Letter: The Examiner of … - Aug 1, 2006 Concerns have been raised that long-term use of Lantus, a genetically-engineered insulin, may cause cancer. The FDA approved Lantus, made by Aventis SA, ... Pay-Per-View - Townsend Letter: The Examiner of... - HighBeam Research Lantus lows - Jul 16, 2007 Lantus (insulin glargine) is a long-acting basal insulin that is supposed to be released slowly and evenly throughout approximately 24 hours. ... HealthCentral.com … Results Support the "Basal Plus" Strategy With LANTUS(R) and... - Oct 9, 2008 After 8-16 weeks of LANTUS(R), patients with blood glucose less than or equal to7.0 ... Additional study findings showed that during LANTUS(R) titration, ... presseportal.de … in Diabetes Care Confirms Basal Therapy with Lantus(R) Improves... - Jun 9, 2005 LANTUS, (A Trial comparing Lantus(R) Algorithms to achieve Normal blood glucose ... "Lantus(R) has been proven to help lower blood sugar levels and can help ... Pay-Per-View - PR Newswire - HighBeam Research Twice-daily Lantus Effective For Reducing Blood Sugars in Type 1 … - Sep 5, 2006 Blood glucose concentration in type 1 diabetes rises in the late afternoon in association with falling plasma insulin levels can be prevented with twice ... Diabetes In Control Here's what someone else said about a Lantus low: - Jul 16, 2007 ..."The result, when I hit a vessel in my leg, was a drop in blood sugar from 180 to 30 in 1/2 hour!" "About a half hour after dinner, I broke out in a sweat, ... HealthCentral.com Press Release: Study Shows Lantus(R) Helped People Living with Type 2... - Jun 7, 2008 Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADA's Recommended Target for Blood Sugar Control. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Lantus (glarine) Insulin Unaffected by Exercise - Mar 22, 2005 No significant difference was observed in the rate of insulin glargine decay on the 2 study days (exercise versus no exercise). ... Diabetes In Control Fortune 40: Stock picks to retire on - Sanofi-Aventis (37) - FORTUNE - Jun 11, 2007 Stroke drug Lovenox is its top seller, and sales are rapidly growing for its insulin brand Lantus. The French pharma giant has managed to grow the franchise ... CNNMoney.com Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra... - Feb 14, 2008 PARIS, February 14 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the Chicago Athenaeum Museum of Architecture and Design has awarded a 2007 ... Free with registration - PR Newswire - AccessMyLibrary.com Ocala Star-Banner (FL) - Mar 24, 2006 I am a diabetic; therefore, I take a lot of insulin such as Lantus, ... Now here is my cost before the new program: Lantus, $67.50 twice monthly; Humalog, ... $2.95 - Ocala Star-Banner - NewsBank => Study Shows Lantus(R) Helped People Living with Type 2 Diabetes … - Jul 6, 2008 SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- Results from a new study presented at the American Diabetes Association's (ADA) 68th Annual Scientific ... FinanzNachrichten.de … (R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) - Apr 30, 2007 FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … ADA Showed that Basal Insulin Therapy with Lantus(R) Achieved... - Jun 13, 2005 Data Presented at ADA Showed that Basal Insulin Therapy with Lantus(R) Achieved Target Glycemic Control in Poorly Controlled Type 2 Diabetes. from PR ... Pay-Per-View - PR Newswire - HighBeam Research … : People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) ... - Sep 10, 2008 Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed ... Pay-Per-View - PR Newswire Europe - HighBeam Research … : People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) ... - Sep 10, 2008 Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed ... Pay-Per-View - PR Newswire - HighBeam Research PBS recommendation offers hope to diabetics. 25/04/2006. ABC News … - Apr 25, 2006 Diabetes Australia in WA has welcomed a recommendation by the Pharmaceutical Benefits Advisory Committee (PBAC) that the long-acting insulin Lantus be ... ABC Regional Online - ABC Regional Online Aventis to ramp up operations in India - May 5, 2008 ...sanofi-aventis launched its long acting insulin, Lantus, in India a few years ago, and the product currently commands about 7 per cent of the Rs 400 crore ... Rediff … pump therapy works better than Lantus[R].(Advertisement) - Interna - Feb 1, 2005 Yale University study finds insulin pump therapy works better than Lantus[R].(Advertisement) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research The New Pen Saves Lantus - May 28, 2007 The original Lantus pen was difficult to use and malfunctioned frequently. This was troublesome for patients and physicians. ... Gerson Lehrman Group … Illustrate Greater A1C Lowering and Cost Benefit Observed With... - Sep 7, 2008 Despite higher drug costs for LANTUS(R), relevant savings were observed in ... LANTUS(R) patients also had on average fewer basal insulin injections per day ... presseportal.de Diabetes 'Champions' Share Their Stories Through Circle of Champions ... - Oct 16, 2008 Lantus(R) is the only 24-hour insulin approved exclusively for use once a day. ... With Lantus(R), the insulin is released into the bloodstream at a ... RedOrbit Aida Turturro -- HBO's Janice Soprano -- takes control of her diabetes - May 1, 2007 Although Lantus is convenient, especially for travelers, -- once a day, no refrigeration -- some patients still need to take an additional short-acting ... $2.95 - Miami Herald - NewsBank FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children... - Oct 29, 2008 Lantus(R) is indicated for the treatment of adult and pediatric patients ... Lantus(R) is the only 24-hour insulin approved exclusively for use once a day. ... International Business Times OTC: New prescription products: Lantus OptiClik.(Sanofi-Aventis... - Feb 4, 2006 3ml cartridges containing insulin glargine 100units/ml Cautions: To be used with the OptiClik device only (available from sanofi-aventis representatives ... $4.95 - Chemist & Druggist - ECNext SoloStar Lantus & Apidra Insulin Pen to Debut - Mar 27, 2007 Sanofi-Aventis is gearing up for the European roll-out of a new disposable insulin pen designed to address a broader spectrum of patient needs than ... Diabetes In Control Diabetic pleads for help as drug price soars - Sep 7, 2005 But it was no longer effective at controlling her condition so she had to switch, on doctor's orders, to another type, Lantus, which costs more than $125 a ... Hawke's Bay Today Is Once-a-Day Insulin Right For You? - Apr 26, 2008 Lantus is a “basalâ€? insulin analogue, meaning it is given once a day either ... The researchers found that Lantus was also associated with a lower risk of ... HealthNews Lantus and Lente and other name confusion amongst diabetes drugs - Aug 8, 2008 An article today in my local newspaper (What's in a name? Mix-ups spur FDA to do more to avoid sound-alike medications) points out that "three years ago, ... HealthCentral.com Weight gain with Lantus - Jan 28, 2008 My parents are in their 80's, have had Type II diabetes for more than 10 years, and were put on Lantus 2 years ago. They also take Metformin and Actos. ... HealthCentral.com Once-a-day insulin subsidised for NZ patients - Jun 26, 2006 Insulin glargine (Lantus) is a long-acting type of insulin that will be funded for people who have the most difficulty controlling their blood sugar levels. ... scoop.co.nz Actress Aida Turturro Tells Americans to Start Now to Talk With Their... - Nov 1, 2007 The pen comes prefilled with Lantus(R), the only 24-hour insulin approved ... "Taking Lantus once a day at the same time each day made an important ... Free with registration - PR Newswire - AccessMyLibrary.com … Results Support the "Basal Plus" Strategy With LANTUS(R) and... - Sep 10, 2008 After 8-16 weeks of LANTUS(R), patients with blood glucose less than or equal ... Treatment with Lantus also resulted in predictable fasting blood glucose ... Pay-Per-View - PR Newswire - HighBeam Research From the pharmacy.(storing Lantus)(drug therapy for Alzheimer's... - Mar 1, 2007 From the pharmacy.(storing Lantus)(drug therapy for Alzheimer's disease )(Qualaquin approved ) ... find Saturday Evening Post articles. Pay-Per-View - Saturday Evening Post - HighBeam Research Standard Long-acting Insulin As Good As Newer Medications - Apr 19, 2007 However, the reviewers found that Lantus and Levemir were almost identical to NPH in ... They suggested a "cautious approach" when using Lantus or Levemir, ... sciencedaily.com Standard Long-Acting Insulin As Good As Newer Medications - Apr 24, 2007 However, the reviewers found that Lantus and Levemir were almost identical to NPH in ... They suggested a "cautious approach" when using Lantus or Levemir, ... emaxhealth.com From the pharmacy.(storing Lantus)(drug therapy for Alzheimer's... - Mar 1, 2007 Quinine Available, More Expensive: People have been taking quinine pills for decades to treat nighttime leg cramps--even though the FDA has long warned that ... $4.95 - Saturday Evening Post - ECNext J&J's Profit Rises 8.9%, Led by Medical Devices - Jul 20, 2005 ...boosted by strong sales of its antistroke drug Plavix, diabetes drug Lantus and cancer drug Eloxatin. In the first half, sales of its biggest drug, ... Subscription - Wall Street Journal Online - Dow Jones & Company Aventis Pharma launches SoloSTAR, a prefilled insulin pen - May 17, 2008 LANTUS® SoloSTAR was first launched in Germany. ... Sanofi-Aventis, the developer, manufacturer and marketer of LANTUS SoloSTAR is currently building ... TopNews New medicines can help lower high blood pressure in lungs - Jan 20, 2008 He was taken off all his oral diabetes medicines and put on Lantus insulin. ... Lantus is a long-acting insulin whose effects remain for 24 hours. ... SouthCoastToday.com - SouthCoastToday.com New Prefilled Disposable Insulin Pen Approved - May 2, 2007 The FDA has approved Sanofi-Aventis' Lantus SoloStar, a new prefilled, once-daily disposable insulin pen for Lantus (insulin glargine) for the treatment of ... Facts and Comparisons Disposable insulin pen.(Products)(Lantus SoloStar)(Brief article) - Sep 1, 2007 The Food and Drug Administration has approved the Lantus SoloStar, a disposable pen prefilled with insulin glargine recombinant (Lantus), which is indicated ... $4.95 - Pediatric News - ECNext Disposable insulin pen.(Products)(Lantus SoloStar)(Brief article) |... - Sep 1, 2007 Disposable insulin pen.(Products)(Lantus SoloStar)(Brief article) ... find Pediatric News articles. The Food and Drug Administration has approved the Lantus ... Pay-Per-View - Pediatric News - HighBeam Research Article: Insulin pen gets thumbs up from FDA.(Diabetes Care)(Brief... - Jun 25, 2007 ...article) ... find Chain Drug Review articles. BRIDGEWATER, NJ -- The Food and Drug Administration has approved Lantus SoloStar, a disposable insulin pen ... Pay-Per-View - Chain Drug Review - HighBeam Research Federal Register 2007 - 72 FR 30595 Determination of Regulatory … - Jun 1, 2007 FDA approved for marketing the human drug product LANTUS (insulin glargine [rDNA ... LANTUS is indicated for once-daily subcutaneous administration for the ... Pay-Per-View - Federal Register 2007 - Loislaw Press Release: Actress Aida Turturro Tells Americans to Start Now to... - Nov 1, 2007 Article: New Study Showed Lantus(R) Plus One, Two or Three Shots of ... ... Article: Study Shows Lantus(R) Helped People Living with Type 2 ... ... Pay-Per-View - PR Newswire - HighBeam Research Big price cut for diabetes drug - Aug 24, 2006 Diabetes Australia has been lobbying for more than a year to have Lantus included on the PBS, arguing there is no other comparable product that provides ... Pay-Per-View - West Australian - Factiva, from Dow Jones A pen that seeks to improve diabetes care - Sep 20, 2008 But instead of ink, the prefilled, disposable Lantus SoloStar releases a ... Indeed, the Lantus SoloStar is changing the way insulin is administered. ... Inquirer.net Sanofi drug 'helps diabetes patients reach target blood sugar' - Jun 9, 2008 Sanofi-Aventis has announced that new results from a clinical study have shown its drug Lantus helps patients with type 2 diabetes achieve their target ... Hays Pharma Blockbuster drug sales lift Sanofi-Aventis profit. - Nov 8, 2005 Sales of Lantus insulin also rose 44 percent to A325 million (US$384.3 million), and multiple sclerosis drug Copaxone boosted sales by 24 percent to A240 ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Liraglutide gives better control than Lantus. - Jul 2, 2007 Liraglutide gives better control than Lantus. Shares in Novo Nordisk jumped 5.9% to $106.98 on June 21 after the Danish diabetes specialist reported strong ... $9.94 - Pharma Marketletter - Alacra Store Lantus SoloStar. - Jun 1, 2007 A prefilled disposable insulin pen (Lantus SoloStar, Sanofi-Aventis) was approved for the once-daily treatment of hyperglycemia in patients with type 1 or ... $9.94 - Formulary - Alacra Store Once-Daily Insulin More Convenient but No More Effective - Mar 28, 2008 GIESSEN, Germany, March 28 -- Once-daily injections of insulin glargine (Lantus) may control type 2 diabetes as well as multiple injections of insulin ... MedPage Today Insulin for type 1 and type 2 diabetes - Oct 3, 2008 The long-acting insulin glargine (Lantus) starts to work within 1 to 2 hours ... Lantus cannot be mixed in the same syringe with other types of insulin. ... MSN Health & Fitness Be Aware of Hypoglycemia Unawareness - Jul 20, 2006 ...use an insulin pump (since a bolus can be delayed until food is ready to be eaten) or inject insulin glargine (brand name Lantus), which has no peak. ... Diabetes Self Management Danish Drug Firm Seeks - Nov 29, 2005 Sanofi-Aventis sells Lantus, a long-acting insulin analog that has a 25% share of all insulin sales in the US market. Novo Nordisk plans to launch a ... Subscription - Wall Street Journal Online - Dow Jones & Company Generex Biotechnology's Oral-lyn matches fast-acting insulin in Phase... - Mar 14, 2005 This is the first report in which patients with Type-1 diabetes, using glargine insulin (Lantus) as their baseline therapy, have been maintained with ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Diabetes: types and activity of insulin.(Pediatric Advisor 2007) - May 31, 2007 Lantus/Levemir: Lantus and Levemir are clear insulins that last 24 hours with ... If your child takes Lantus or Levemir, he or she will still need to take ... $4.95 - Clinical Reference Systems - ECNext What I'm Doing About Health Issues - Apr 2, 2007 I take Lantus and Novolin R (prn on a sliding scale), Neurontin, and Lisinopril. I take Requip. I have come to this website to find friends and support. ... HealthCentral.com To Pump or Not To Pump? - Feb 16, 2007 I have decided on trying Lantus and Humalog for a while to see if that works. My A1c's are higher off the pump, but I'm still working on it. ... HealthCentral.com Byetta, diaTribe, and Me - Apr 3, 2007 I have now been taking Lantus shots daily for about a year and things are looking up. I still need to take supplemental pills and of course watch my diet ... HealthCentral.com Scriptlines: Lantus OptiClik.(Brief Article) - Jan 7, 2006 The 3ml cartridges are suitable for use with the OptiClik device, which is available from sanofi-aventis representatives. ... $4.95 - Chemist & Druggist - ECNext 'I fought the law… and I won' - Dec 7, 2008 There a consultant simply ordered that the patient be given Lantus, ... Patients using the Lantus treatment use an average of 20 to 30% less insulin, ... Malta Today Diabetics herald one-a-day insulin - Feb 18, 2005 A product called Lantus is "a really outstanding insulin'' for helping both type ... Lantus provides daylong glucose-lowering effects without the peaks and ... Pay-Per-View - The Record - ProQuest Archiver Brand Names/Synonyms: Lantus is also known by the following brand names and/or synonymsLantus; Lantus Drug Category: Lantus is categorized under the following by the FDA: Hypoglycemic Agents; insulins (68:20.08) Dosage Forms: SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Recombinant human insulin |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |